Suchergebnisse - "Schlenk, Richard Friedrich"

PubPharm (58)

1

Predicting successful hematopoietic stem cell collection in healthy allogeneic donors

enthalten in: Transfusion medicine and hemotherapy | October 2023

von Kayser, S. | Schlenk, R. | Steiner, M. | +2

2

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia

enthalten in: Haematologica | February 23, 2023

von Kayser, S. | Ho, A. | Baldus, C. | +4

3

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

enthalten in: Journal of hematology & oncology | 17 August 2023

von Heitmann, J. | Schlenk, R. | Dörfel, D. | +15

4

Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: The lancet / Haematology | July 2023

von Döhner, H. | Weber, D. | Krzykalla, J. | +34

5

Overlapping features of therapy-related and de novo NPM1-mutated AML

enthalten in: Blood | April 13, 2023

von Othman, J. | Meggendorfer, M. | Tiacci, E. | +28

6

Update on current treatments for adult acute myeloid leukemia : to treat acute myeloid leukemia intensively or non-intensively? That is the question

enthalten in: Haematologica | February, 2023

von Jaramillo Segura, S. | Schlenk, R.

7

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial

enthalten in: Nature cancer | 2023

von Denkinger, C. | Janssen, M. | Schäkel, U. | +30

8

Q-HAM : a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

enthalten in: Trials | 2023

von Jaramillo Segura, S. | Le Cornet, L. | Kratzmann, M. | +23

9

Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia

enthalten in: Scientific reports | 08 September 2023

von Schlenk, R. | Weber, D. | Krzykalla, J. | +18

10

Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

enthalten in: Clinical epigenetics | 26 October 2023

von Schmutz, M. | Zucknick, M. | Schlenk, R. | +8

1
2
3
4
5
6
Nächster »
[6]